Hidapharma, a prominent player in the pharmaceutical industry, is headquartered in Iran (IR) and operates extensively across the Middle East and beyond. Founded in 2003, the company has established itself as a leader in the development and manufacturing of high-quality pharmaceutical products, including generic medications and innovative therapies. Hidapharma is renowned for its commitment to quality and compliance with international standards, which sets its offerings apart in a competitive market. With a diverse portfolio that addresses various therapeutic areas, the company has achieved significant milestones, including numerous certifications and partnerships that enhance its market position. As a trusted name in the pharmaceutical sector, Hidapharma continues to contribute to healthcare advancements, ensuring access to essential medications while maintaining a focus on research and development.
How does Hidapharma's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Hidapharma's score of 0 is lower than 70% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Hidapharma, headquartered in Iran (IR), currently does not have available data on its carbon emissions, as no specific emissions figures have been provided. Additionally, there are no documented reduction targets or climate pledges outlined in their initiatives. This absence of data suggests that the company may still be in the early stages of formalising its climate commitments or may not have publicly disclosed its emissions profile. As the pharmaceutical industry increasingly prioritises sustainability, it is essential for companies like Hidapharma to establish clear carbon reduction strategies and transparency in emissions reporting to align with global climate goals.
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Hidapharma is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.